Chronic myelomonocytic leukemia and myelodysplastic syndrome/myeloproliferative overlap syndromes

Phuong L Nguyen, Curtis A. Hanson

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Practicing hematologists and hematopathologists have long recognized that patients with myelodysplastic syndromes (MDS) typically present with cytopenia(s), and those with chronic myeloproliferative disorders (CMPD) typically present with elevated blood counts and organomegaly, but there are also patients who have clinical, laboratory, and/or pathologic features of both MDS and CMPD, and those patients are not easily assigned to either category. Thus, prior to the publication of the World Health Organization (WHO) classification of hematopoietic neoplasms (see chaps. 1 and 9), some patients with left-shifted neutrophilia and absolute monocytosis and morphologic features of dysgranulopoiesis were classified as chronic myelomonocytic leukemia (CMML) under the family of MDS, whereas others who also had left-shifted neutrophilia and morphologic features of dysgranulopoiesis but less monocytosis were classified as atypical chronic myeloid leukemia (aCML) under the CMPD umbrella.

Original languageEnglish (US)
Title of host publicationMyelodysplastic Syndromes
Subtitle of host publicationPathobiology and Clinical Management, Second Edition
PublisherCRC Press
Pages285-310
Number of pages26
ISBN (Electronic)9781420074406
ISBN (Print)1420074393, 9781420074390
StatePublished - Jan 1 2008

Fingerprint

Leukemia, Myelomonocytic, Chronic
Myelodysplastic Syndromes
Myeloproliferative Disorders
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
Hematologic Neoplasms
Publications

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nguyen, P. L., & Hanson, C. A. (2008). Chronic myelomonocytic leukemia and myelodysplastic syndrome/myeloproliferative overlap syndromes. In Myelodysplastic Syndromes: Pathobiology and Clinical Management, Second Edition (pp. 285-310). CRC Press.

Chronic myelomonocytic leukemia and myelodysplastic syndrome/myeloproliferative overlap syndromes. / Nguyen, Phuong L; Hanson, Curtis A.

Myelodysplastic Syndromes: Pathobiology and Clinical Management, Second Edition. CRC Press, 2008. p. 285-310.

Research output: Chapter in Book/Report/Conference proceedingChapter

Nguyen, PL & Hanson, CA 2008, Chronic myelomonocytic leukemia and myelodysplastic syndrome/myeloproliferative overlap syndromes. in Myelodysplastic Syndromes: Pathobiology and Clinical Management, Second Edition. CRC Press, pp. 285-310.
Nguyen PL, Hanson CA. Chronic myelomonocytic leukemia and myelodysplastic syndrome/myeloproliferative overlap syndromes. In Myelodysplastic Syndromes: Pathobiology and Clinical Management, Second Edition. CRC Press. 2008. p. 285-310
Nguyen, Phuong L ; Hanson, Curtis A. / Chronic myelomonocytic leukemia and myelodysplastic syndrome/myeloproliferative overlap syndromes. Myelodysplastic Syndromes: Pathobiology and Clinical Management, Second Edition. CRC Press, 2008. pp. 285-310
@inbook{71e8ae01a4a6429bbd1675504c46341f,
title = "Chronic myelomonocytic leukemia and myelodysplastic syndrome/myeloproliferative overlap syndromes",
abstract = "Practicing hematologists and hematopathologists have long recognized that patients with myelodysplastic syndromes (MDS) typically present with cytopenia(s), and those with chronic myeloproliferative disorders (CMPD) typically present with elevated blood counts and organomegaly, but there are also patients who have clinical, laboratory, and/or pathologic features of both MDS and CMPD, and those patients are not easily assigned to either category. Thus, prior to the publication of the World Health Organization (WHO) classification of hematopoietic neoplasms (see chaps. 1 and 9), some patients with left-shifted neutrophilia and absolute monocytosis and morphologic features of dysgranulopoiesis were classified as chronic myelomonocytic leukemia (CMML) under the family of MDS, whereas others who also had left-shifted neutrophilia and morphologic features of dysgranulopoiesis but less monocytosis were classified as atypical chronic myeloid leukemia (aCML) under the CMPD umbrella.",
author = "Nguyen, {Phuong L} and Hanson, {Curtis A.}",
year = "2008",
month = "1",
day = "1",
language = "English (US)",
isbn = "1420074393",
pages = "285--310",
booktitle = "Myelodysplastic Syndromes",
publisher = "CRC Press",

}

TY - CHAP

T1 - Chronic myelomonocytic leukemia and myelodysplastic syndrome/myeloproliferative overlap syndromes

AU - Nguyen, Phuong L

AU - Hanson, Curtis A.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Practicing hematologists and hematopathologists have long recognized that patients with myelodysplastic syndromes (MDS) typically present with cytopenia(s), and those with chronic myeloproliferative disorders (CMPD) typically present with elevated blood counts and organomegaly, but there are also patients who have clinical, laboratory, and/or pathologic features of both MDS and CMPD, and those patients are not easily assigned to either category. Thus, prior to the publication of the World Health Organization (WHO) classification of hematopoietic neoplasms (see chaps. 1 and 9), some patients with left-shifted neutrophilia and absolute monocytosis and morphologic features of dysgranulopoiesis were classified as chronic myelomonocytic leukemia (CMML) under the family of MDS, whereas others who also had left-shifted neutrophilia and morphologic features of dysgranulopoiesis but less monocytosis were classified as atypical chronic myeloid leukemia (aCML) under the CMPD umbrella.

AB - Practicing hematologists and hematopathologists have long recognized that patients with myelodysplastic syndromes (MDS) typically present with cytopenia(s), and those with chronic myeloproliferative disorders (CMPD) typically present with elevated blood counts and organomegaly, but there are also patients who have clinical, laboratory, and/or pathologic features of both MDS and CMPD, and those patients are not easily assigned to either category. Thus, prior to the publication of the World Health Organization (WHO) classification of hematopoietic neoplasms (see chaps. 1 and 9), some patients with left-shifted neutrophilia and absolute monocytosis and morphologic features of dysgranulopoiesis were classified as chronic myelomonocytic leukemia (CMML) under the family of MDS, whereas others who also had left-shifted neutrophilia and morphologic features of dysgranulopoiesis but less monocytosis were classified as atypical chronic myeloid leukemia (aCML) under the CMPD umbrella.

UR - http://www.scopus.com/inward/record.url?scp=85057460301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057460301&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85057460301

SN - 1420074393

SN - 9781420074390

SP - 285

EP - 310

BT - Myelodysplastic Syndromes

PB - CRC Press

ER -